Literature DB >> 27103528

Association of genetic risk factors with cognitive decline: the PATH through life project.

Shea J Andrews1, Debjani Das2, Nicolas Cherbuin3, Kaarin J Anstey3, Simon Easteal2.   

Abstract

We examined the association of 28 single nucleotide polymorphisms (SNPs), previously associated with dementia or cognitive performance, with tests assessing episodic memory, working memory, vocabulary, and perceptual speed in 1689 nondemented older Australians of European ancestry. In addition to testing each variant individually, we assessed the collective association of the 12-risk SNPs for late-onset Alzheimer's disease using weighted and unweighted genetic risk scores. Significant associations with cognitive performance were observed for APOE ε4 allele, ABCA7-rs3764650, CR1-rs3818361, MS4A4E-rs6109332, BDNF-rs6265, COMT-rs4680, CTNNBL-rs6125962, FRMD4A-rs17314229, FRMD4A-rs17314229, intergenic SNP chrX-rs12007229, PDE7A-rs10808746, SORL1-rs668387, and ZNF224-rs3746319. In addition, the weighted genetic risk score was associated with worse performance on episodic memory. The identification of genetic risk factors, that act individually or collectively, may help in screening for people with elevated risk of cognitive decline and for understanding the biological pathways that underlie cognitive decline.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognitive decline; Genetic risk scores; Population-based study; SNPs

Mesh:

Year:  2016        PMID: 27103528     DOI: 10.1016/j.neurobiolaging.2016.02.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

1.  ABCA7 risk variant in healthy older African Americans is associated with a functionally isolated entorhinal cortex mediating deficient generalization of prior discrimination training.

Authors:  Neha Sinha; Zachariah M Reagh; Nicholas J Tustison; Chelsie N Berg; Ashlee Shaw; Catherine E Myers; Diane Hill; Michael A Yassa; Mark A Gluck
Journal:  Hippocampus       Date:  2018-12-10       Impact factor: 3.899

2.  Evaluation of APOE Genotype and Ability to Perform Activities of Daily Living Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lacey Wright Heinsberg; Eleanor Turi; Dianxu Ren; Elizabeth Crago; Sheila Alexander; Ansley Grimes Stanfill; Yvette Perry Conley
Journal:  Biol Res Nurs       Date:  2017-12-19       Impact factor: 2.522

3.  [Verification of a sporadic Alzheimer disease model in SORL1 gene knockout mice].

Authors:  Fang-Bo Lin; Xin Liu; Jing-Wen Xie; Jing Luo; Xia-Lu Feng; De-Ren Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

4.  Polygenic Score for Alzheimer Disease and cognition: The mediating role of personality.

Authors:  Yannick Stephan; Angelina R Sutin; Martina Luchetti; Pauline Caille; Antonio Terracciano
Journal:  J Psychiatr Res       Date:  2018-10-23       Impact factor: 4.791

Review 5.  Cognitive Genomics: Recent Advances and Current Challenges.

Authors:  Joan Fitzgerald; Derek W Morris; Gary Donohoe
Journal:  Curr Psychiatry Rep       Date:  2020-01-10       Impact factor: 5.285

6.  Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.

Authors:  Richard Sherva; Alden Gross; Shubhabrata Mukherjee; Ryan Koesterer; Philippe Amouyel; Celine Bellenguez; Carole Dufouil; David A Bennett; Lori Chibnik; Carlos Cruchaga; Jorge Del-Aguila; Lindsay A Farrer; Richard Mayeux; Leanne Munsie; Ashley Winslow; Stephen Newhouse; Andrew J Saykin; John S K Kauwe; Paul K Crane; Robert C Green
Journal:  Alzheimers Dement       Date:  2020-06-23       Impact factor: 16.655

7.  Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life.

Authors:  Lindsey I Sinclair; Christopher W Pleydell-Pearce; Ian N M Day
Journal:  Neurobiol Learn Mem       Date:  2017-10-12       Impact factor: 2.877

Review 8.  Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease.

Authors:  Olav M Andersen; Ina-Maria Rudolph; Thomas E Willnow
Journal:  Acta Neuropathol       Date:  2016-09-16       Impact factor: 17.088

9.  Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.

Authors:  Shea J Andrews; Ranmalee Eramudugolla; Jorge I Velez; Nicolas Cherbuin; Simon Easteal; Kaarin J Anstey
Journal:  Alzheimers Res Ther       Date:  2017-03-04       Impact factor: 6.982

10.  From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.

Authors:  Judith R Harrison; Sumit Mistry; Natalie Muskett; Valentina Escott-Price
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.